AVNS
Avanos Medical Inc
NYSE: AVNS · HEALTHCARE · MEDICAL DEVICES
$24.64
-0.06% today
Updated 2026-04-30
Market cap
$1.15B
P/E ratio
—
P/S ratio
1.64x
EPS (TTM)
$-1.57
Dividend yield
—
52W range
$9 – $25
Volume
1.4M
Avanos Medical Inc (AVNS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $139.60M | $202.60M | $223.80M | $147.90M | $97.60M | $188.80M | $144.20M | $-145.60M | $-74.50M | $-2.50M | $87.30M | $90.90M | $32.40M | $100.70M | $74.70M |
| Capital expenditures | $39.70M | $40.80M | $49.00M | $78.50M | $70.40M | $29.10M | $43.20M | $49.10M | $50.60M | $20.20M | $21.00M | $19.30M | $17.80M | $17.80M | $31.60M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.60M | $5.30M | $6.00M | $7.90M | $14.10M | $14.80M | $12.60M | $10.50M | $10.50M | $12.10M | $13.20M | $15.90M | $15.80M | $13.80M | $12.60M |
| Free cash flow | $99.90M | $161.80M | $174.80M | $69.40M | $27.20M | $159.70M | $101.00M | $-194.70M | $-125.10M | $-22.70M | $66.30M | $71.60M | $14.60M | $82.90M | $43.10M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $680.00M | $0.00 | $0.00 | $0.00 | — | $5.30M | $3.40M | $6.20M | $1.70M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $104.90M | $-19.50M | $-15.80M | $106.00M | $164.80M | $-181.10M | $-96.70M | $11.00M | $12.20M | — | — | — |